{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:22:11Z","timestamp":1792081331019,"version":"4.4.0"},"reference-count":59,"publisher":"American Psychiatric Association Publishing","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1999,8,1]]},"DOI":"10.1176\/ajp.156.8.1138","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:19:38Z","timestamp":1659111578000},"page":"1138-1148","source":"Crossref","is-referenced-by-count":103,"title":["Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms"],"prefix":"10.1176","volume":"156","author":[{"given":"Douglas F.","family":"Levinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Umapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamado","family":"Musthaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1568CHDJAACA","doi-asserted-by":"crossref","unstructured":"Kasanin J: The acute schizoaffective psychoses. Am J Psychiatry 1933; 90:97\u2013126","DOI":"10.1176\/ajp.90.1.97"},{"key":"R1568CHDDAICB","doi-asserted-by":"crossref","unstructured":"Welner A, Croughan JL, Robins E: The group of schizoaffective and related psychoses\u2014critique, record, follow-up, and family studies, I: a persistent enigma. Arch Gen Psychiatry 1974; 31:628\u2013631","DOI":"10.1001\/archpsyc.1974.01760170028004"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Abrams R, Taylor MA: Mania and schizo-affective disorder, manic type: a comparison. Am J Psychiatry 1976; 133:1445\u20131447","DOI":"10.1176\/ajp.133.12.1445"},{"key":"R1568CHDECABJ","doi-asserted-by":"crossref","unstructured":"Tsuang MT, Dempsey GM: Long-term outcome of major psychoses, II: schizoaffective disorder compared with schizophrenia, affective disorders, and a surgical control group. Arch Gen Psychiatry 1979; 36:1302\u20131304","DOI":"10.1001\/archpsyc.1979.01780120032004"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Rosenthal NE, Rosenthal LN, Stallone F, Dunner DL, Fieve RR: Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry 1980; 37:804\u2013810","DOI":"10.1001\/archpsyc.1980.01780200082009"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Brockington IF, Wainwright S, Kendell RE: Manic patients with schizophrenic or paranoid symptoms. Psychol Med 1980; 10:73\u201383","DOI":"10.1017\/S0033291700039611"},{"key":"R1568CHDIHCBF","doi-asserted-by":"crossref","unstructured":"Himmelhoch JA, Fuchs CZ, May SJ, Symons BJ, Neil JF: When a schizoaffective diagnosis has meaning. J Nerv Ment Dis 1981; 169:277\u2013282","DOI":"10.1097\/00005053-198105000-00002"},{"key":"R1568CHDJGHIG","doi-asserted-by":"crossref","unstructured":"Baron M, Gruen R, Asnis L, Kane J: Schizoaffective illness, schizophrenia and affective disorders: morbidity risk and genetic transmission. Acta Psychiatr Scand 1982; 65:253\u2013262","DOI":"10.1111\/j.1600-0447.1982.tb00845.x"},{"key":"R1568CHDCCDCD","doi-asserted-by":"crossref","unstructured":"Kendler KS, Gruenberg AM, Tsuang MT: A DSM-III family study of the nonschizophrenic psychotic disorders. Am J Psychiatry 1986; 143:1098\u20131105","DOI":"10.1176\/ajp.143.9.1098"},{"key":"R1568CHDEHHFE","doi-asserted-by":"crossref","unstructured":"Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert O, Levinson DF: Continuity and discontinuity of affective disorders and schizophrenia: results of a controlled family study. Arch Gen Psychiatry 1993; 50:871\u2013883","DOI":"10.1001\/archpsyc.1993.01820230041004"},{"key":"R1568CHDFJEFI","doi-asserted-by":"crossref","unstructured":"Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35:773\u2013782","DOI":"10.1001\/archpsyc.1978.01770300115013"},{"key":"R1568CHDBCFFA","doi-asserted-by":"crossref","unstructured":"Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Howes MJ, Kane J, Pope HG, Rounsaville B, Wittchen H-U: The Structured Clinical Interview for DSM-III-R (SCID), II: multisite test-retest reliability. Arch Gen Psychiatry 1992; 49:630\u2013636","DOI":"10.1001\/archpsyc.1992.01820080038006"},{"key":"R1568CHDEDHFA","doi-asserted-by":"crossref","unstructured":"Faraone SV, Blehar M, Pepple J, Moldin SO, Norton J, Nurnberger JI, Malaspina D, Kaufmann CA, Reich T, Cloninger CR, DePaulo JR, Berg K, Gershon ES, Kirch DG, Tsuang MT: Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies. Psychol Med 1996; 26:401\u2013410","DOI":"10.1017\/S0033291700034796"},{"key":"R1568CHDDJCEE","unstructured":"Martin RL, Cloninger CR, Guze SB, Clayton PJ: Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry 1985; 46:9\u201313"},{"key":"R1568CHDBGCEF","doi-asserted-by":"crossref","unstructured":"McGlashan TH, Carpenter WT Jr: Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 1976; 33:231\u2013239","DOI":"10.1001\/archpsyc.1976.01770020065011"},{"key":"R1568CHDCCHBI","doi-asserted-by":"crossref","unstructured":"Siris SG: Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. Schizophr Bull 1991; 17:75\u201398","DOI":"10.1093\/schbul\/17.1.75"},{"key":"R1568CHDCGDEC","doi-asserted-by":"crossref","unstructured":"Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI Jr, Maxwell ME, Schreiber J, Dauphinais D, Dingman CW II, Guroff JJ: A controlled family study of chronic psychoses. Arch Gen Psychiatry 1988; 45:328\u2013337","DOI":"10.1001\/archpsyc.1988.01800280038006"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Maj M: Lithium prophylaxis of schizoaffective disorders: a prospective study. J Affect Disord 1988; 14:129\u2013135","DOI":"10.1016\/0165-0327(88)90055-9"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Bouman TK, Kampen JGN, Ormel J, Slooff CJ: The effectiveness of lithium prophylaxis in bipolar and unipolar depressions and schizoaffective disorders. J Affect Disord 1986; 11:275\u2013280","DOI":"10.1016\/0165-0327(86)90079-0"},{"key":"R1568CHDHFAFB","unstructured":"Mattes JA, Nayak D: Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives. Biol Psychiatry 1984; 19:445\u2013449"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Brewerton TD, Reus VJ: Lithium carbonate and l-tryptophan in the treatment of bipolar and schizoaffective disorders. Am J Psychiatry 1983; 140:757\u2013760","DOI":"10.1176\/ajp.140.6.757"},{"key":"atypb7","unstructured":"Goode DJ, Manning A: A comparison of bupropion alone and with haloperidol in schizoaffective disorder, depressed type. J Clin Psychiatry 1983; 44:253\u2013255"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Kufferle B, Lenz G: Classification and course of schizo-affective psychoses: follow-up of patients treated with lithium. Psychiatr Clin (Basel) 1983; 16:169\u2013177","DOI":"10.1159\/000283965"},{"key":"R1568CHDDFBCE","unstructured":"Carman JS, Bigelow LB, Wyatt RJ: Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. J Clin Psychiatry 1981; 42:124\u2013128"},{"key":"R1568CHDJEADB","doi-asserted-by":"crossref","unstructured":"Biederman J, Lerner Y, Belmaker RH: Combination of lithium carbonate and haloperidol in schizoaffective disorder. Arch Gen Psychiatry 1979; 36:327\u2013333","DOI":"10.1001\/archpsyc.1979.01780030093009"},{"key":"R1568CHDFHIBD","doi-asserted-by":"crossref","unstructured":"Brockington IF, Kendell RE, Kellett JM, Curry SH, Wainwright S: Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. Br J Psychiatry 1978; 133:162\u2013168","DOI":"10.1192\/bjp.133.2.162"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"Okuma T, Yamashita I, Takahashi R, Itoh H, Kurihara M, Otsuki S, Watanabe S, Sarai K, Hazama H, Inanaga K: Clinical efficacy of carbamazepine in affective, schizoaffective and schizophrenic disorders. Pharmacopsychiatry 1989; 22:47\u201353","DOI":"10.1055\/s-2007-1014577"},{"key":"R1568CHDIAJGH","doi-asserted-by":"crossref","unstructured":"Okuma T, Yamashita I, Takahashi R, Itoh H, Otsuki S, Watanabe S, Sarai K, Hazama H, Inanaga K: A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders. Acta Psychiatr Scand 1989; 80:250\u2013259","DOI":"10.1111\/j.1600-0447.1989.tb01334.x"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Ries RK, Wilson L, Bokan JA, Chiles JA: ECT in medication-resistant schizoaffective disorder. Compr Psychiatry 1981; 22:167\u2013173","DOI":"10.1016\/0010-440X(81)90065-1"},{"key":"R1568CHDHHEAD","doi-asserted-by":"crossref","unstructured":"M\u00fcller-Siecheneder F, M\u00fcller MJ, Hillert A, Szegedi, A, Wetzel H, Benkert O: Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 1998; 18:111\u2013120","DOI":"10.1097\/00004714-199804000-00003"},{"key":"R1568CHDJJBJI","unstructured":"Keck PE Jr, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, Holtman HM, Depreist M: Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorders and psychotic mood disorders. J Clin Psychiatry 1995; 56:466\u2013470"},{"key":"R1568CHDDGBJE","unstructured":"Banov MD, Zarate CA, Tohen M, Scialabba D, Wines JD, Kolbrener M, Kim J, Cole JO: Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994; 55:295\u2013300"},{"key":"R1568CHDCIDCG","doi-asserted-by":"crossref","unstructured":"Ceskova E, Svetska J: Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Pharmacopsychiatry 1993; 26:121\u2013124","DOI":"10.1055\/s-2007-1014355"},{"key":"R1568CHDFHEHC","unstructured":"McElroy SL, Dessain EC, Pope HG Jr, Cole JO, Keck PE Jr, Frankenberg FR, Aizley HG, O\u2019Brien S: Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991; 52:411\u2013414"},{"key":"R1568CHDFJDHH","doi-asserted-by":"crossref","unstructured":"Naber D, Hippius H: The European experience with use of clozapine. Hosp Community Psychiatry 1990; 41:886\u2013890","DOI":"10.1176\/ps.41.8.886"},{"key":"R1568CHDJJGAE","doi-asserted-by":"crossref","unstructured":"Tollefson GD, Sanger TM, Lu Y: Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry 1998; 55:250\u2013258","DOI":"10.1001\/archpsyc.55.3.250"},{"key":"R1568CHDCEIBG","doi-asserted-by":"crossref","unstructured":"Marder SR, Davis JM, Chouinard G: The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 1997; 58:538\u2013546","DOI":"10.4088\/JCP.v58n1205"},{"key":"R1568CHDIJCGE","doi-asserted-by":"crossref","unstructured":"Hogarty GE, McEvoy JP, Ulrich RF, DiBarry AL, Bartone P, Cooley S, Hammill K, Carter M, Munetz MR, Perel J: Pharmacotherapy of impaired affect in recovering schizophrenic patients. Arch Gen Psychiatry 1995; 52:29\u201341","DOI":"10.1001\/archpsyc.1995.03950130029004"},{"key":"R1568CHDHADBE","doi-asserted-by":"crossref","unstructured":"Siris SG, Bermanzohn PC, Mason SE, Shuwall MA: Maintenance imipramine therapy for secondary depression in schizophrenia. Arch Gen Psychiatry 1994; 51:109\u2013115","DOI":"10.1001\/archpsyc.1994.03950020033003"},{"key":"R1568CHDHEIJG","unstructured":"Dufresne RL, Valentino D, Kass DJ: Thioridazine improves affective symptoms in schizophrenic patients. Psychopharmcol Bull 1993; 29:249\u2013255"},{"key":"R1568CHDHFDEF","doi-asserted-by":"crossref","unstructured":"Kramer MS, Vogel WH, DiJohnson C, Dewey DA, Sheves P, Cavicchia S, Litle P, Schmidt R, Kimes I: Antidepressants in \u201cdepressed\u201d schizophrenic inpatients: a controlled trial. Arch Gen Psychiatry 1989; 46:922\u2013928","DOI":"10.1001\/archpsyc.1989.01810100064012"},{"key":"R1568CHDJBHJD","doi-asserted-by":"crossref","unstructured":"Dufresne RL, Kass DJ, Becker RE: Bupropion and thiothixene vs placebo and thiothixene in the treatment of depression in schizophrenia. Drug Dev Res 1988; 12:259\u2013266","DOI":"10.1002\/ddr.430120308"},{"key":"R1568CHDFDIAB","doi-asserted-by":"crossref","unstructured":"Lerner Y, Mintzer Y, Schestatzky M: Lithium combined with haloperidol in schizophrenic patients. Br J Psychiatry 1988; 153:359\u2013362","DOI":"10.1192\/bjp.153.3.359"},{"key":"R1568CHDDFGDI","doi-asserted-by":"crossref","unstructured":"Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB: Adjunctive imipramine in the treatment of postpsychotic depression. Arch Gen Psychiatry 1987; 44:533\u2013539","DOI":"10.1001\/archpsyc.1987.01800180043008"},{"key":"R1568CHDIAAEF","doi-asserted-by":"crossref","unstructured":"Becker RE: Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia. Am J Psychiatry 1983; 140:208\u2013211","DOI":"10.1176\/ajp.140.2.208"},{"key":"atypb11","doi-asserted-by":"crossref","unstructured":"Johnson DAW: A double-blind trial of nortriptyline for depression in chronic schizophrenia. Br J Psychiatry 1981; 139:97\u2013101","DOI":"10.1192\/bjp.139.2.89"},{"key":"R1568CHDGBBGF","doi-asserted-by":"crossref","unstructured":"Kurland AA, Nagaraju A: Viloxazine and the depressed schizophrenic: methodological issues. J Clin Pharmacol 1981; 21:37\u201341","DOI":"10.1002\/j.1552-4604.1981.tb01730.x"},{"key":"atypb12","doi-asserted-by":"crossref","unstructured":"Waehrens J, Gerlach J: Antidepressant drugs in anergic schizophrenia. Acta Psychiatr Scand 1980; 61:438\u2013444","DOI":"10.1111\/j.1600-0447.1980.tb00882.x"},{"key":"R1568CHDCFHFF","doi-asserted-by":"crossref","unstructured":"Prusoff BA, Williams DH, Weissman MM, Astrachan BM: Treatment of secondary depression in schizophrenia. Arch Gen Psychiatry 1979; 36:569\u2013575","DOI":"10.1001\/archpsyc.1979.01780050079010"},{"key":"R1568CHDHCEIC","unstructured":"Singh AN, Saxena B, Nelson HL: A controlled clinical study of trazodone in chronic schizophrenic patients with pronounced depressive symptomatology. Curr Ther Res 1978; 23:485\u2013501"},{"key":"atypb13","doi-asserted-by":"crossref","unstructured":"McElroy SL, Keck PE Jr, Pope HG Jr: Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol 1987; 7:16\u201324","DOI":"10.1097\/00004714-198702000-00004"},{"key":"atypb14","unstructured":"Puzynski S, Klosiewicz L: Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders. Psychopharmacol Bull 1984; 20:151\u2013159"},{"key":"R1568CHDEADCG","unstructured":"Schaff MR, Fawcett J, Zajecka JM: Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry 1993; 54:380\u2013384"},{"key":"R1568CHDEBDCB","doi-asserted-by":"crossref","unstructured":"Chouinard G, Annable L, Serrano M, Albert JM, Charette R: Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. Arch Gen Psychiatry 1975; 32:1295\u20131307","DOI":"10.1001\/archpsyc.1975.01760280093009"},{"key":"R1568CHDFFGEH","doi-asserted-by":"crossref","unstructured":"Meltzer HY, Okayli G: Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995; 152:183\u2013190","DOI":"10.1176\/ajp.152.2.183"},{"key":"R1568CHDJJGDJ","doi-asserted-by":"crossref","unstructured":"Small JG, Kellams JJ, Milstein V, Moore J: A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. Am J Psychiatry 1975; 132:1315\u20131317","DOI":"10.1176\/ajp.132.12.1315"},{"key":"R1568CHDFBFIJ","doi-asserted-by":"crossref","unstructured":"Growe GA, Crayton JW, Klass DB, Evans H, Strizich M: Lithium in chronic schizophrenia. Am J Psychiatry 1979; 136:454\u2013455","DOI":"10.1176\/ajp.1979.136.4a.454"},{"key":"R1568CHDGIBIC","unstructured":"Johnson G: Differential response to lithium carbonate in manic-depressive and schizoaffective disorders. Dis Nerv Syst 1970; 13:613\u2013615"},{"key":"R1568CHDBAAEA","doi-asserted-by":"crossref","unstructured":"Prien RF, Cafe EM, Klett JC: A comparison of lithium carbonate and chlorpramazine in the treatment of excited schizoaffectives. Arch Gen Psychiatry 1972; 27:182\u2013189","DOI":"10.1001\/archpsyc.1972.01750260034005"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ajp.psychiatryonline.org\/doi\/10.1176\/ajp.156.8.1138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:44:42Z","timestamp":1722386682000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.156.8.1138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8,1]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8,1]]}},"alternative-id":["10.1176\/ajp.156.8.1138"],"URL":"https:\/\/doi.org\/10.1176\/ajp.156.8.1138","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8,1]]}}}